BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37295765)

  • 1. Nicotinamide mononucleotide (NMN) ameliorated Nonylphenol-induced learning and memory impairment in rats via the central 5-HT system and the NAD
    Huang H; Shi J; Li Z; Rang Y; Li W; Xiao X; Chen C; Liu C
    Food Chem Toxicol; 2023 Aug; 178():113878. PubMed ID: 37295765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMN Alleviates NP-Induced Learning and Memory Impairment Through SIRT1 Pathway in PC-12 Cell.
    Li Z; Liu H; Han W; Zhu S; Liu C
    Mol Neurobiol; 2023 May; 60(5):2871-2883. PubMed ID: 36745337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Nicotinamide mononucleotide activates NAD+/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice.
    Li HR; Liu Q; Zhu CL; Sun XY; Sun CY; Yu CM; Li P; Deng XM; Wang JF
    Redox Biol; 2023 Jul; 63():102745. PubMed ID: 37201414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons.
    Chandrasekaran K; Choi J; Arvas MI; Salimian M; Singh S; Xu S; Gullapalli RP; Kristian T; Russell JW
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-emptive Short-term Nicotinamide Mononucleotide Treatment in a Mouse Model of Diabetic Nephropathy.
    Yasuda I; Hasegawa K; Sakamaki Y; Muraoka H; Kawaguchi T; Kusahana E; Ono T; Kanda T; Tokuyama H; Wakino S; Itoh H
    J Am Soc Nephrol; 2021 Jun; 32(6):1355-1370. PubMed ID: 33795425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2.
    Hasegawa K; Sakamaki Y; Tamaki M; Wakino S
    Sci Rep; 2022 Aug; 12(1):13712. PubMed ID: 35962139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
    Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
    PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotinamide mononucleotide pretreatment improves long-term isoflurane anesthesia-induced cognitive impairment in mice.
    Xu J; Chen X; Liu S; Wei Z; Xu M; Jiang L; Han X; Peng L; Gu X; Xia T
    Behav Brain Res; 2024 Feb; 458():114738. PubMed ID: 37931707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects.
    Yamane T; Imai M; Bamba T; Uchiyama S
    Clin Nutr ESPEN; 2023 Aug; 56():83-86. PubMed ID: 37344088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide mononucleotide promotes pancreatic islet function through the SIRT1 pathway in mice after severe burns.
    Liu X; Li D; Liu Z; Song Y; Zhang B; Zang Y; Zhang W; Niu Y; Shen C
    Burns; 2022 Dec; 48(8):1922-1932. PubMed ID: 35123833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide mononucleotide inhibits oxidative stress-induced damage in a SIRT1/NQO-1-dependent manner.
    Nakajo T; Kitajima N; Katayoshi T; Tsuji-Naito K
    Toxicol In Vitro; 2023 Dec; 93():105683. PubMed ID: 37640247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD
    Li X; Li Y; Li F; Chen Q; Zhao Z; Liu X; Zhang N; Li H
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotinamide mononucleotide based hyaluronic acid methacryloyl hybrid hydrogel regulating stem cells fate for bone regeneration via SIRT1/RUNX2 signaling.
    Li J; Yan S; Yang X; Ren X; Qu H; Song J
    Int J Biol Macromol; 2024 Mar; 261(Pt 2):129905. PubMed ID: 38311136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity.
    Zou XD; Guo SQ; Hu ZW; Li WL
    Mol Med Rep; 2016 May; 13(5):4058-64. PubMed ID: 27035562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide mononucleotide attenuates HIF-1α activation and fibrosis in hypoxic adipose tissue
    Wu K; Li B; Ma Y; Tu T; Lin Q; Zhu J; Zhou Y; Liu N; Liu Q
    Front Endocrinol (Lausanne); 2023; 14():1099134. PubMed ID: 36777361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH.
    Nadtochiy SM; Wang YT; Nehrke K; Munger J; Brookes PS
    J Mol Cell Cardiol; 2018 Aug; 121():155-162. PubMed ID: 29958828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide mononucleotide administration after sever hypoglycemia improves neuronal survival and cognitive function in rats.
    Wang X; Hu X; Zhang L; Xu X; Sakurai T
    Brain Res Bull; 2020 Jul; 160():98-106. PubMed ID: 32380185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
    Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
    Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment.
    Chen X; Amorim JA; Moustafa GA; Lee JJ; Yu Z; Ishihara K; Iesato Y; Barbisan P; Ueta T; Togka KA; Lu L; Sinclair DA; Vavvas DG
    Aging (Albany NY); 2020 Dec; 12(24):24504-24521. PubMed ID: 33373320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.